Avion Pharmaceuticals

GA · United States · Reporting entity ID 100000005590

Total reported 2019–2025

$1.40M

#1,177 of 2,960 reporting companies — 0% of all reported industry payments

$874K in general payments across 47,840 records, plus $530K in research funding across 68 records.

How it breaks down

General payments $873,656

Research funding $529,764

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.